$SGRY

Surgery Partners jumps on $1.15B hospital sale deal By Investing.com

Surgery Partners (NASDAQ:SGRY) rose 5.8% after agreeing to sell two Idaho Falls hospitals to Intermountain Health for about $1.15B. Surgery Partners expects about $795M for its ownership interests, with cash proceeds subject to purchase price adjustments. The deal needs approvals and regulatory steps and is expected to close in coming months. 2026 outlook was reaffirmed excluding the deal.

Original reporting
Published Jul 24, 2026, 4:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 4:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$SGRY
Bullish
medium confidence
Mentioned
$SGRY
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$SGRYBullishMed
01

Why it matters

The transaction provides substantial consideration and is expected to close in coming months, but execution depends on physician approvals, HSR expiration, regulatory approvals, and third-party consents.

02

Market read

Deal value, closing conditions, and reaffirmed 2026 guidance excluding transaction impact create a tradable catalyst with approval-timeline risk.

03

What to watch

Watch for any changes to the 2026 outlook once the company provides transaction financial impact details after closing, and monitor physician board approval and third-party consent progress.

Relevance 8/10Novelty 7/10Timing: Deal announcement ahead of Q2 2026 results on Aug 10, 2026.

Background

Surgery Partners is pursuing a portfolio optimization strategy and announced an agreement to sell Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health.

Company-level read

Ticker impact

$SGRYBullishMedium confidence
Context

Surgery Partners agreed to sell two Idaho Falls hospitals to Intermountain Health for about $1.15B, with cash proceeds at closing.

Expected impact

Near-term upside bias while deal approval and HSR/regulatory timelines remain intact; volatility likely around approval milestones and Q2 earnings.

Evidence & confidence

The article discloses deal consideration ($795M to SGRY for ownership interests), closing conditions (physician approvals, HSR, regulatory approvals, third-party consents), and that 2026 outlook is reaffirmed excluding transaction impact.

Market effects

Highlights ongoing consolidation and portfolio reshaping in ambulatory and hospital-adjacent healthcare services.

Could affect Idaho Falls area hospital ownership dynamics, though the article does not quantify local competitive impact.

Limited, as the transaction is regional and not presented as a cross-border or systemic healthcare policy shift.

Counterpoint

The deal’s closing is months away and depends on multiple approvals and purchase price adjustments, so the market may be over-discounting near-term certainty.

Key entities

  • Surgery Partners Inc

    NASDAQ-listed operator that agreed to sell two Idaho Falls hospitals for about $1.15B total consideration.

  • Intermountain Health

    Health system purchasing Mountain View Hospital and Idaho Falls Community Hospital from Surgery Partners.

  • Eric Evans

    CEO who characterized the deal as the largest step in Surgery Partners’ portfolio optimization strategy.

Related articles

$SGRYMed

Why Is Surgery Partners Stock Gaining Friday? - Surgery Partners (NASDAQ:SGRY)

Surgery Partners (SGRY) said it will sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for about $795 million, valuing the facilities at roughly $1.15 billion, subject to physician partner approval. The company reaffirmed fiscal 2026 revenue of $3.35 billion to $3.45 billion and adjusted EBITDA of at least $530 million.

$SGRYMedAI 8/10

Surgery Partners To Sell 2 Idaho Hospitals To Intermountain For $795 Mln, Backs FY View; Shares Jump

Surgery Partners (SGRY) said it signed agreements to sell its interests in Mountain View Hospital and Idaho Falls Community Hospital in Idaho to Intermountain Health for about $795 million. The hospitals were valued around $1.15 billion. Surgery Partners reaffirmed its FY2026 revenue of $3.35B to $3.45B and adjusted EBITDA of at least $530M excluding the deal. Shares rose to about $16.51.

$SGRYMed

Why Surgery Partners (SGRY) Stock Is Trading Up Today

Surgery Partners (SGRY) shares rose about 2.7% in the morning to around $17.15 after Cantor Fitzgerald reiterated an “Overweight” rating and set an $18.00 price target. Cantor cited some softness in Q2 ambulatory surgery center and outpatient nursing data, but kept a positive view. Other analysts expect profitability this year.

MedAI 9/10

Nielsen To Buy DoubleVerify For $2.15 Billion In Ad Measurement Deal

Nielsen agreed to buy DoubleVerify in an all-cash deal valued at about $2.15 billion, paying $13.60 per share, a 30% premium to the stock’s 60-day VWAP as of Aug. 5. The boards approved; closing is expected by Q1 2027, subject to approvals. Pro forma revenue is expected to exceed $4 billion.

$RTXMedAI 8/10

RTX wins up to $745.4 million deal for SM-3 Block IIA interceptors, extending ballistic missile interceptor production through 2031

RTX won a U.S. Department of War deal worth up to $745.4 million for SM-3 Block IIA ballistic missile interceptors, extending production through 2031. The first tranche totals $275.6 million from the U.S. defense budget and $277.6 million from Japan’s MoD. SM-3 Block IIA uses a kinetic warhead and Mk 41 launchers. It saw documented combat use in April 2024 against Iranian missiles.